Highlights of prescribing information these highlights do. Aranesp has not been shown to improve quality of life, fatigue, or patient wellbeing. Le traitement par aranesp doit etre instaure par des medecins ayant lexperience des indications mentionnees cidessus. The ongoing randomized trial to reduce cardiovascular events with aranesp therapy treat is anticipated to add further clarity to this issue. Aranesp darbepoetin alfa is a manmade form of a protein that helps your body produce red blood cells. Aranesp is a solution for injection in a vial, a prefilled syringe or a prefilled pen.
The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. Aranespa darbepoetin alfa for injection description aranesp is an erythropoiesis stimulating protein, closely related to erythropoietin, that is produced in chinese hamster ovary cho cells by recombinant dna technology. Darbepoetin alfa side effects, dosage, interactions drugs. These events included myocardial infarction, stroke, and congestive heart failure. Erythropoietin stimulating agents esas, such as eprex epoetin alpha or aranesp darbepoetin alpha, are manufactured versions of a protein that may be administered to stimulate erythropoiesis in the absence of kidney function. Aranesp darbepoetin alfa is an erythropoiesisstimulating protein that is produced in chinese hamster ovary cho cells by recombinant dna technology. Aranesp is a 165amino acid protein that differs from recombinant human erythropoietin in containing 5 nlinked oligosaccharide chains, whereas recombinant human erythropoietin contains 3 chains. Nov 09, 2018 darbepoetin alfa is a manmade form of a protein that helps your body produce red blood cells. Increased mortality, serious cardiovascular events, thromboembolic events, stroke and increased risk of tumor progression or. Chronic kidney disease ckd in patients on dialysis and patients not on dialysis.
Darbepoetin alfa is used to treat anemia caused by chemotherapy or chronic kidney disease darbepoetin alfa may also be used for purposes not listed in this medication guide. Aranesp 10 microgrammes, solution injectable en seringue preremplie. Aranesp in albumin injection interactions with other. Aranesp is an erythropoiesisstimulating agent esa indicated for the treatment of anemia due to. Aranesp in polysorbate injection interactions with other. This protein may be reduced when you have kidney failure or use certain medications. Information for healthcare professionals erythropoiesis stimulating agents esa aranesp darbepoetin alfa, epogen epoetin alfa, and procrit epoetin alfa report serious adverse events to fdas medwatch reporting system by completing a form on line at. Amgen safety net foundation asnf is an independent nonprofit patient assistance program established in 2001, sponsored by amgen. Maintain the route of administration intravenous or subcutaneous injection. Aranesp is a sterile product, manufactured without preservatives. Find patient medical information for aranesp in polysorbate injection on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. The food and drug administration fda approved darbepoetin alfa aranesp for treatment of anemia as sociated with chronic renal failure crf in patients on dialysis and patients not on dialysis. Erythropoiesis stimulating agents esa aranesp darbepoetin.
Shared care guidelines york and scarborough formulary. Sep 14, 2001 following iv administration to adult crf patients, aranesp serum. Aranesp, inndarbepoetin alfa european medicines agency. Soda pdf merge tool allows you to combine two or more documents into a single pdf file for free. Any number of drug, remaining in a filled syringe, be destroyed. My son has a serious kidney disease and receives aranesp monthly with no side effects. Anemia due to chronic kidney disease ckd, including patients on. Following iv administration to these patients, aranesp serum. Jan 30, 2019 administer aranesp once every 2 weeks in patients who were receiving epoetin alfa once weekly. Find, read and cite all the research you need on researchgate.
Pdf on sep 1, 2008, gunnar sterner and others published conversion from epoetin beta to darbepoetin. If approved, this extended dosing of aranesp may allow physicians to treat anemia on the same schedule as chemotherapy, which is frequently administered every three weeks. The aranesp sureclick prefilled pen delivers the complete dose of each presentation. Quickly merge multiple pdf files or part of them into a single one. Instructions for use aranesp airuhnesp darbepoetin alfa. Aranesp sureclick patient information leaflet pil emc. Patients with kidney failure also have trouble absorbing and. In patients with cancer receiving hormonal agents, biologic products, or radiotherapy, unless also receiving concomitant myelosuppressive chemotherapy. Does aranesp in albumin solution interact with other medications. Highlights of prescribing information these highlights do not include all the information needed to use aranesp safely and effectively. Maurice had aranesp for anaemia but the same warnings came out for it this past summer. The manufacturer of the drug also filed an application with the fda on september 18, 2001, to receive an indication for treatment of anemia in.
Aranesp darbepoetin alfa therapy for oncology patients. Aranesp darbepoetin alfa therapy for oncology patients 1 aranesp darbepoetin alfa therapy for oncology patients oncologic drugs advisory committeemay 4, 2004 2 amgen guests. Thus, anaemia management is rapidly evolving, as new trial designs and an increasing number of treatment options continue to advance the understanding of hb control in patients with ckd. Learn about aranesp from patients first hand experiences and trusted online health resources, including dosage, side effects and interactions. Highlights of prescribing information these highlights do not include all the information needed to use aranespsafely and effectively. Aranesp 25, 40, 60, 100, 200, 300 micrograms solution for injection in vial. Aranesp 60 microgrammes solution injectable en stylo prerempli. Darbepoetin alfa is used to treat anemia caused by chemotherapy or chronic kidney disease.
Highlights of prescribing information these highlights do not. This fda approved drug stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. One of the worlds largest independent biotechnology companies, amgen was established in thousand oaks, california in 1980. No trial has identified a hemoglobin target level, aranesp dose, or dosing strategy that does not increase these risks 2. The manufacturer of the drug also filed an application with the fda on september 18, 2001, to receive an indication for treatment of anemia in patients with cancer robert hunter, amgen medical. Seems some kidney patients experienced problems with it and that is when the medical community became aware of the problems.
Estimate the starting weekly dose of aranesp for adults and pediatric patients on the basis of the weekly epoetin alfa dose at the time of substitution see table 1. Instructions for use aranesp air uhnesp darbepoetin alfa injection singledose prefilled syringe singleject guide to parts before use after use plunger rod finger grip label and expiration date used plunger rod yellow safety guard extended yellow safety guard syringe barrel medicine window with markings gray needle cap on gray needle. Aranesp is contraindicated in patients with uncontrolled hypertension. Aranesp darbepoetin alfa, also known as novel erythropoiesis stimulating protein nesp, is an erythropoiesis stimulating protein closely related to erythropoietin that is produced in chinese hamster ovary cells by recombinant dna technology. During the first several months of therapy, blood pressure and the presence of premonitory neurologic symptoms should be monitored closely. Seizures have occurred in patients participating in clinical trials of aranesp and rhuepo. When fewer red blood cells are produced, you can develop a condition called anemia.
See what the interactions are and for which people. These medications may interact and cause very harmful effects. Aranesp should be discontinued in any patient with evidence of prca and the patient evaluated for the presence of antibodies to erythropoietin products. New phase 3 data show potential benefits of aranespr dosed. It has a 3fold longer serum halflife compared to epoetin alpha and epoetin beta. Drug interactions are reported among people who take aranesp and vidaza together. In controlled trials, patients with chronic kidney disease such as renal impairment or renal failure experienced greater risks for mortality, serious adverse cardiovascular reactions, and stroke when administered erythropoiesisstimulating agents esas such as darbepoetin alfa to target a hemoglobin concentration greater than 11 gdl. January 2014 shared care guidelines drug darbepoetin alfa aranesp for use in chronic renal disease adults introduction darbepoetin alfa aranesp is a novel erythropoiesisstimulating agent esa. Aranesp complete drug information, side effects and. Sep 19, 2008 the ongoing randomized trial to reduce cardiovascular events with aranesp therapy treat is anticipated to add further clarity to this issue. It is a hyperglycosylated derivative of erythropoietin, which.
Information for healthcare professionals erythropoiesis stimulating agents esa aranesp darbepoetin alfa, epogen epoetin alfa, and procrit epoetin alfa report serious adverse events to. Aranesp exists in various strengths, from 25 to 500 micrograms per millilitre. Using aranesp to target a hemoglobin level of greater than 11 gdl increases the risk of serious adverse cardiovascular reactions and has not been shown to provide additional benefit 5. This protein may be reduced when you have kidney failure. This lets patients get larger doses of these growth factors than. Dailymed aranesp darbepoetin alfa injection, solution. Aranesp darbepoetin alfa side effects, images, uses.
Anaemia is when your blood does not contain enough red blood cells and the symptoms may be fatigue, weakness and shortness of breath. Aranesp darbepoetin alfa is used to treat a lower than normal number of red blood cells anemia caused by chronic kidney disease in patients on dialysis and not on dialysis and anemia caused by chemotherapy that will be used for at least two months after starting aranesp. Amgens thousand oaks staff in 2017 numbered 5,125 7. It is used to treat anemia caused by chronic kidney failure and chemotherapy. Aranesp, epogen, procrit fchp 420 cvs caremark specialty pharmacy 2211 sanders road nbt6 northbrook, il 60062 phone. Does aranesp syringe interact with other medications.
Aranesp est presente en seringue pre remplie prete a linjection et en stylo pre rempli pret a linjection sureclicktm. Instructions for use aranesp airuhnesp darbepoetin. Darbepoetin alfa may also be used for purposes not listed in this medication guide. Aranesp and vidaza drug interactions a study of fda data. Aranesp darbepoetin alfa dosing, indications, interactions. Anemia secondary to myelodysplastic syndrome mds endogenous serum erythropoietin level of. Darbepoetin alfa side effects, dosage, interactions. Jan 30, 2019 increased mortality, myocardial infarction, stroke, and thromboembolism.
Aranesp in albumin injection interactions with other medication. This lets patients get larger doses of these growth factors than their body would make. Aranesp darbepoetin alfa side effects, images, uses, dosage. Singleuse prefilled sureclick autoinjector this patient package insert contains information and directions for patients and their. It is recommended that the dose of aranesp be decreased if the hemoglobin increase darbepoetin alfa fda. Chronic kidney disease ckd in patients on dialysis and. Oct 01, 2017 growth factors for treating chronic myelomonocytic leukemia these substances occur naturally in the body, but scientists have found a way to make them in large amounts. Anemia is a common complication of ckd because the kidneys are unable to manufacture enough. Asnf was designed to assist patients who have a financial need, and are uninsured or the insurance plan excludes the amgen medicine. Pdf merge combinejoin pdf files online for free soda pdf.
Darbepoetin aranesp shared care guideline page 1 of 4 version number. Aranesp is indicated for the treatment of anemia associated with chronic under the trade name recormon. Aranesp darbepoetine alfa posologie, effets secondaires. This study is created by ehealthme based on reports of 153 people who take aranesp and vidaza from food and drug administration fda, and is updated regularly. The most commonly reported side effects in clinical trials were fatigue, edema, nausea, vomiting, diarrhea, fever, and dyspnea. Aranesp darbepoetin alfa dose, indications, adverse effects. Aranesp product monograph page 8 of 50 neurologic seizures use with caution in patients with a history of seizures. Gsks says depot hiv injection works over three years red blood cell stimulator aranesp darbepoetin alfa pfizer gets fda panel recommendation for biosimilar epo epogen shrank by a third last year thanks in part to switching of some patients to amgens longacting esa aranesp darbepoetin alfa and competition from rochevifors aranesp. Growth factors for treating chronic myelomonocytic leukemia. It was launched in 2001 and is indicated for the treatment of anemia associated with ckd in both patients on dialysis and patients not on dialysis and the treatment of anemia due to concomitant myelosuppressive chemotherapy in patients with nonmyeloid malignancies. The dose should be adjusted for each patient to achieve and maintain a target hemoglobin.
Cancer patients receiving chemotherapy the recommended starting dose for aranesp is 2. Administer aranesp once every 2 weeks in patients who were receiving epoetin alfa once weekly. These substances occur naturally in the body, but scientists have found a way to make them in large amounts. Erythropoiesis stimulating agents medical clinical. Aranesp and other esas increased the risks for death, serious cardiovascular events, and stroke in controlled clinical trials of patients with cancer. Your doctor has given you aranesp an antianaemic to treat your anaemia. Aranesp darbepoetin alfa injection, for intravenous or subcutaneous use initial u.
Our pdf merger allows you to quickly combine multiple pdf files into one single pdf document, in just a few clicks. Hematopoietic growth factors are hormonelike substances that stimulate bone marrow to produce blood cells. Darbepoetin alfa is a manmade form of a protein that helps your body produce red blood cells. Darbepoetin alfa helps your body make more red blood cells.
Does the patient require a higher dosage quantity limit exception. Aranesp for injection amgen, drug reference encyclopedia. Esas increase the risk of death, myocardial infarction, stroke, venous thromboembolism, thrombosis of vascular access and tumor progression or recurrence. Aranesp darbepoetin alfa dose, indications, adverse. Use of darbepoetin alfa in the treatment of anaemia of.
666 78 732 1234 881 963 241 853 1183 480 1174 599 663 175 808 350 992 1140 373 1408 1071 1292 1345 947 1494 1020 1111 1259 694 1346 881 323 731 785 1266